<p><span class="css-901oao css-16my406 r-poiln3 r-bcqeeo r-qvutc0">The Subject Expert Committee (SEC) is scheduled to meet on Wednesday to discuss Dr Reddy’s application seeking emergency use approval for the Sputnik V coronavirus vaccine. </span></p>.<p><br />Dr Reddy's has been working with the Russian Direct Investment Fund (RDIF) to hold small clinical trials of Sputnik V in India. </p>.<p>The vaccine has proved 91.6% effective against Covid-19, based on late-stage trials in Russia, results published in the Lancet medical journal showed . </p>.<p>More than a million people in Russia have received Sputnik V, which is marketed abroad by the RDIF and has been approved for emergency use in Algeria, Argentina, Bolivia, Mexico and Serbia.</p>.<p>RDIF expects India, the world's biggest vaccine maker, to produce about 300 million doses of Sputnik V this year. Hetero Biopharma is making more than 100 million doses.</p>.<p><em><strong>More to follow...</strong></em></p>
<p><span class="css-901oao css-16my406 r-poiln3 r-bcqeeo r-qvutc0">The Subject Expert Committee (SEC) is scheduled to meet on Wednesday to discuss Dr Reddy’s application seeking emergency use approval for the Sputnik V coronavirus vaccine. </span></p>.<p><br />Dr Reddy's has been working with the Russian Direct Investment Fund (RDIF) to hold small clinical trials of Sputnik V in India. </p>.<p>The vaccine has proved 91.6% effective against Covid-19, based on late-stage trials in Russia, results published in the Lancet medical journal showed . </p>.<p>More than a million people in Russia have received Sputnik V, which is marketed abroad by the RDIF and has been approved for emergency use in Algeria, Argentina, Bolivia, Mexico and Serbia.</p>.<p>RDIF expects India, the world's biggest vaccine maker, to produce about 300 million doses of Sputnik V this year. Hetero Biopharma is making more than 100 million doses.</p>.<p><em><strong>More to follow...</strong></em></p>